Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Arecor Therapeutics plc

Headquarters: Cambridge, United Kingdom
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Sarah Jennifer Howell, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -1.34
Exchange/Ticker 1: LSE:AREC
Exchange/Ticker 2: N/A
Latest Market Cap: $18,743,582

BioCentury | Mar 19, 2024
Deals

Deals Report: AZ buys Amolyt for Phase III asset, Novartis takes out IFM Due

Plus: Merck gains access to Pearl Bio’s synthetic biology platform for up to $1B, Hansoh partners with Biotheus on bispecific ADCs, and more
Items per page:
1 - 1 of 1